CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness
CBD Life Sciences, Inc. (CBDL) has launched a groundbreaking CBD Horse Paste, a veterinarian-designed solution for equine wellness. This first-of-its-kind product addresses physical and psychological challenges in horses, offering relief from muscle stiffness, joint pain, and anxiety. The paste, containing 500mg of premium CBD per syringe, is designed for maximum absorption and easy administration.
The launch positions CBDL to capitalize on the growing global CBD market, projected to reach $47.22 billion by 2028. The company has already seen a 1405.46% revenue increase since February 2024. The equine CBD market is expected to experience significant growth, potentially driving CBDL's future success in the fast-growing CBD industry.
CBD Life Sciences, Inc. (CBDL) ha lanciato una pasta di CBD per cavalli innovativa, una soluzione progettata da veterinari per il benessere equino. Questo prodotto, unico nel suo genere, affronta le sfide fisiche e psicologiche nei cavalli, offrendo sollievo da rigidità muscolare, dolori articolari e ansia. La pasta, contenente 500 mg di CBD di alta qualità per siringa, è progettata per una massima assorbibilità e un facile utilizzo.
Il lancio posiziona CBDL per capitalizzare sul crescente mercato globale del CBD, previsto per raggiungere i 47,22 miliardi di dollari entro il 2028. L'azienda ha già registrato un aumento del fatturato del 1405,46% dal febbraio 2024. Si prevede che il mercato del CBD per cavalli subirà una significativa crescita, potenzialmente guidando il futuro successo di CBDL nell'industria del CBD in rapida espansione.
CBD Life Sciences, Inc. (CBDL) ha lanzado una pasta de CBD para caballos, una solución diseñada por veterinarios para el bienestar equino. Este producto, único en su tipo, aborda los desafíos físicos y psicológicos en los caballos, ofreciendo alivio de la rigidez muscular, el dolor articular y la ansiedad. La pasta, que contiene 500 mg de CBD premium por jeringa, está diseñada para una máxima absorción y fácil administración.
El lanzamiento posiciona a CBDL para capitalizar el creciente mercado global de CBD, que se proyecta alcanzará los 47.22 mil millones de dólares para 2028. La empresa ya ha visto un aumento del 1405.46% en sus ingresos desde febrero de 2024. Se espera que el mercado de CBD equino experimente un crecimiento significativo, lo que podría impulsar el futuro éxito de CBDL en la industria de CBD en rápido crecimiento.
CBD Life Sciences, Inc. (CBDL)는 수의사가 설계한 말 건강을 위한 혁신적인 CBD 말용 페이스트를 출시했습니다. 이 제품은 말의 신체적 및 심리적 문제를 다루며, 근육 경직, 관절 통증 및 불안으로부터의 완화를 제공합니다. 이 페이스트는 500mg의 프리미엄 CBD를 포함하고 있으며 최대 흡수와 용이한 투여를 위해 설계되었습니다.
이번 출시는 CBDL이 2028년까지 472억 2천만 달러에 이를 것으로 예상되는 글로벌 CBD 시장의 성장에 발맞추어 나가도록 하고 있습니다. 회사는 이미 2024년 2월 이후 1405.46%의 수익 증가를 경험했습니다. 말용 CBD 시장은 상당한 성장을 경험할 것으로 예상되며, 이는 빠르게 성장하는 CBD 산업에서 CBDL의 미래 성공을 이끌 것입니다.
CBD Life Sciences, Inc. (CBDL) a lancé une pâte de CBD pour chevaux révolutionnaire, une solution conçue par des vétérinaires pour le bien-être équin. Ce produit sans précédent répond aux défis physiques et psychologiques chez les chevaux, offrant un soulagement contre la raideur musculaire, les douleurs articulaires et l'anxiété. La pâte, contenant 500 mg de CBD de haute qualité par seringue, est conçue pour une absorption maximale et une administration facile.
Ce lancement positionne CBDL pour tirer parti du marché mondial du CBD, qui devrait atteindre 47,22 milliards de dollars d'ici 2028. La société a déjà enregistré une augmentation de 1405,46 % de ses revenus depuis février 2024. Le marché du CBD équin devrait connaître une croissance significative, ce qui pourrait propulser le succès futur de CBDL dans l'industrie du CBD en plein essor.
CBD Life Sciences, Inc. (CBDL) hat eine bahnbrechende CBD-Paste für Pferde auf den Markt gebracht, eine von Tierärzten entwickelte Lösung für das Wohlbefinden der Pferde. Dieses einzigartige Produkt stellt sich den physischen und psychologischen Herausforderungen von Pferden und bietet Linderung bei Muskelsteifheit, Gelenkschmerzen und Angstzuständen. Die Paste enthält 500 mg hochwertiges CBD pro Spritze und ist für maximale Aufnahme und einfache Anwendung konzipiert.
Der Start positioniert CBDL optimal, um vom wachsenden globalen CBD-Markt zu profitieren, der bis 2028 voraussichtlich 47,22 Milliarden US-Dollar erreichen wird. Das Unternehmen hat bereits einen Umsatzanstieg von 1405,46% seit Februar 2024 verzeichnet. Der Markt für CBD bei Pferden wird voraussichtlich ein erhebliches Wachstum erfahren, was möglicherweise den zukünftigen Erfolg von CBDL in der schnell wachsenden CBD-Industrie antreiben könnte.
- Launch of innovative CBD Horse Paste, first of its kind in the market
- 1405.46% revenue increase since February 2024
- Potential for significant growth in the equine CBD market
- Positioning to capitalize on the projected $47.22 billion global CBD market by 2028
- None.
The annual economic impact of the equine industry is significant - involving some
SCOTTSDALE, AZ / ACCESSWIRE / October 3, 2024 / CBD Life Sciences, Inc. (CBDL), an industry leader in innovative CBD solutions, proudly announces the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges.
A Game-Changer in the Equine Wellness Market
Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides.
"By creating the CBD Horse Paste, we are revolutionizing equine wellness with a product that not only relieves physical discomfort but also calms behavioral issues. This is the first solution of its kind in the market, and we believe it has the potential to transform the industry," said Lisa Nelson, President and CEO of CBD Life Sciences, Inc.
Positioned for Explosive Growth
With the global CBD market projected to reach
CBDL has already experienced remarkable growth in 2024, with a
Key Benefits of CBD Horse Paste
Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness.
Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety
Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners
Delicious Flavor: The paste's flavor ensures horses readily accept it.
Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions
Innovative CBD for Equine Wellness
The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.
A Bright Future for CBDL
With products like the CBD Horse Paste, CBD Life Sciences, Inc. continues to position itself as a leader in the animal health space. By tapping into the multi-billion-dollar CBD industry and expanding its equine product line, CBDL is set to capture new market segments and drive sustained revenue growth.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
Related Images
|
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What is the new product launched by CBD Life Sciences (CBDL)?
How much CBD does each syringe of CBDL's Horse Paste contain?
What revenue growth has CBDL experienced in 2024?
What is the projected value of the global CBD market by 2028?
